Composite paraganglioma-ganglioneuroma with atypical catecholamine profile and phenylethanolamine N-methyltransferase expression: a case report and literature review.

Composite tumors Phenylethanolamine N-methyltransferase Pheochromocytomas and paragangliomas

Journal

Endocrine journal
ISSN: 1348-4540
Titre abrégé: Endocr J
Pays: Japan
ID NLM: 9313485

Informations de publication

Date de publication:
11 Nov 2023
Historique:
medline: 13 11 2023
pubmed: 13 11 2023
entrez: 12 11 2023
Statut: aheadofprint

Résumé

Pheochromocytomas and paragangliomas (PPGLs) are rare tumors that secrete catecholamines and arise from the adrenal medulla or extra-adrenal sympathetic ganglia. These tumors secrete adrenaline and noradrenaline, but paragangliomas usually produce only noradrenaline because of the lack of phenylethanolamine N-methyltransferase (PNMT) expression. Composite paragangliomas, which are complex tumors consisting of multiple types of neuroblastic cells, are extremely rare. We present the case of a 46-year-old woman with an atypical catecholamine profile who was preoperatively diagnosed with pheochromocytoma. However, postoperative pathology revealed that the patient had an extra-adrenal paraganglioma accompanied by a ganglioneuroma, which led to the diagnosis of a composite tumor. Interestingly, PNMT is expressed in both paragangliomas and ganglioneuromas. In addition, we reviewed reported composite paragangliomas and compared their clinical features with those of composite pheochromocytomas. We also discuss various aspects of the etiology of composite paragangliomas and the mechanism by which PNMT is expressed in tumors.

Identifiants

pubmed: 37952980
doi: 10.1507/endocrj.EJ23-0271
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Yuriko Sasaki (Y)

Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Maki Kanzawa (M)

Department of Diagnostic Pathology, Kobe University Hospital, Kobe 650-0017, Japan.

Masaaki Yamamoto (M)

Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Keitaro Kanie (K)

Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan.

Hironori Bando (H)

Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan.

Kei Yoshino (K)

Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan.

Yushi Hirota (Y)

Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Katsumi Shigemura (K)

Division of Urology, Department of Organ Therapeutics, Faculty of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Masato Fujisawa (M)

Division of Urology, Department of Organ Therapeutics, Faculty of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Wataru Ogawa (W)

Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Hidenori Fukuoka (H)

Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan.

Classifications MeSH